Covaxin has been approved for 6-12-year old children by DGCI

Covaxin approved for children 6-12 years by dgci

NewDelhi: Bharat Biotech's Covaxin has been approved for emergency use for children aged 6-12 years by the Drug Controller General of India (DCGI). Apart from this, DCGI has also approved Zayed Cadila's Zycov D vaccine for emergency use for children above 12 years of age. Two doses of which will be applied. The decision comes after a meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI), in which data was sought from Bharat Biotech for administering the COVID-19 vaccine Covaxin to children in the age group of 2-12 years. 

Read more: Corbevex vaccine to be given to children of 5-11 years in India: DGCI

Currently, the Corbevax vaccine is being given to children aged 12-14 years. The vaccination for 15-18-year olds has started on January 3 this year. He is being given a dose of Covaxin. However, later this campaign was extended from March 16, which also included children of 12-14 years. He is being given Corbevax. In this way, now children above 12 years of age will get three corona vaccines in the country.

The covid cases of Omicron corona variant are on the rise again in India, after the outbreak in China. According to the top scientist, the chances of a fourth covid wave in India are less due to improved immunity in the citizens after the mass covid vaccination program initiated by the Centre. However, many state governments like Delhi and UP have made masks and covid protocols mandatory in public places to check the surge.

To date, India has exported around 17.04 crore covid vaccines to about 96 countries as part of the UN’s COVAX program.

Read more: Booster dose prices of Covaxin, Covishield cut to Rs.225